Immunex, Abgenix, Amgen
Showing 1 - 25 of 75
DLBCL (DLBCL), Primary Mediastinal Large B-cell Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)
Active, not recruiting
- Diffuse Large B-Cell Lymphoma (DLBCL)
- +4 more
- EPOCH
- Rituximab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Neutropenia Trial in Montevideo (Pegfilgastrim Megalabs, Pegfilgastim Amgen)
Recruiting
- Neutropenia
- Pegfilgastrim Megalabs
- Pegfilgastim Amgen
-
Montevideo, BrazilMarcos Giusti
Apr 8, 2022
Colo-rectal Cancer Trial in Manchester (therascreen® KRAS RGQ PCR Kit)
Recruiting
- Colo-rectal Cancer
- therascreen® KRAS RGQ PCR Kit
-
Manchester, United KingdomQIAGEN Gaithersburg, Inc
Apr 20, 2022
Melanoma Patients Treated With IMLYGIC® to Characterize Risk of
Recruiting
- Melanoma
- Herpetic Infection
-
Jefferson City, Missouri
- +16 more
Apr 11, 2022
Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial Trial in
Completed
- Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial
- Information collection
-
Mobile, Alabama
- +58 more
Sep 29, 2021
Chronic Kidney Disease Trial in Ho Chi Minh City (Stimus)
Active, not recruiting
- Chronic Kidney Disease
- Stimus
-
Ho Chi Minh City, VietnamNANOGEN Pharmaceutical Biotechnology JSC
Nov 23, 2022
Gout Attack Trial in New Brunswick (Etanercept, Triamcinolone Acetonide)
Suspended
- Gout Attack
- Etanercept
- Triamcinolone Acetonide
-
New Brunswick, New JerseyRutgers, Robert Wood Johnson Medical School, Clinical Research C
May 10, 2021
Breast Cancer Trial in Stony Brook (Denosumab)
Completed
- Breast Cancer
-
Stony Brook, New YorkStony Brook University Cancer Center
Jan 19, 2022
Anemia, Chronic Kidney Disease Requiring Chronic Dialysis Trial in Ho Chi Minh City (Stimus (NNG-DEPO))
Active, not recruiting
- Anemia
- Chronic Kidney Disease Requiring Chronic Dialysis
- Stimus (NNG-DEPO)
-
Ho Chi Minh City, VietnamNANOGEN Pharmaceutical Biotechnology JSC
Jan 4, 2023
Advanced Solid Tumors, Carcinoid, Colorectal Cancer Trial in Poland, Spain, United States (Modified FOLFOX6, Conatumumab,
Completed
- Advanced Solid Tumors
- +8 more
- Modified FOLFOX6
- +3 more
-
Duarte, California
- +11 more
Feb 3, 2021
Arthroplasty, Replacement, Hip Trial in Los Angeles (Denosumab)
Withdrawn
- Arthroplasty, Replacement, Hip
-
Los Angeles, CaliforniaKeck Medicine of USC
Nov 7, 2020
Hyperlipidemias Trial in Boston (Evolocumab, Statins (Cardiovascular Agents))
Recruiting
- Hyperlipidemias
- Evolocumab
- Statins (Cardiovascular Agents)
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 18, 2022
Infusion Reaction, Monoclonal Antibody Trial in Clovis (Montelukast 10 Mg Oral Tablet)
Recruiting
- Infusion Reaction
- Monoclonal Antibody
- Montelukast 10 Mg Oral Tablet
-
Clovis, CaliforniaCommunity Cancer Institute
Nov 8, 2021
Cat Allergy, Cat Hypersensitivity Trial in United States (AMG 157, Cat Immunotherapy, Cat Immunotherapy Placebo)
Completed
- Cat Allergy
- Cat Hypersensitivity
- AMG 157
- +3 more
-
Los Angeles, California
- +8 more
Apr 23, 2020
PETRA: PErtuzumab and Trastuzumab Biosimilars Real Life
Not yet recruiting
- HER-2 Positive Breast Cancer
- Efficacy of the Pertuzumab-Trastuzumab combination
-
Clermont-Ferrand, France
- +5 more
Nov 20, 2020
Osteoporosis Trial in Tehran (Denosumab, calcium, vitamin D)
Unknown status
- Osteoporosis
- Denosumab
- +2 more
-
Tehran, Iran, Islamic Republic ofRheumatology Center of Iran
Jul 8, 2020
Colorectal Cancer, Metastases Trial (Best supportive care, Panitumumab)
Completed
- Colorectal Cancer
- Metastases
- Best supportive care
- Panitumumab
- (no location specified)
Jul 9, 2018
Colorectal Cancer Trial (Oxaliplatin Based Chemotherapy, Panitumumab, Irinotecan Based Chemotherapy)
Completed
- Colorectal Cancer
- Oxaliplatin Based Chemotherapy
- +3 more
- (no location specified)
Sep 20, 2018
Pharmacokinetic Bioequivalence Study in Human Healthy Volunteers Trial in Ahmedabad (INTP5, US Neulasta)
Completed
- Pharmacokinetic Bioequivalence Study in Human Healthy Volunteers
- INTP5
- US Neulasta
-
Ahmedabad, Gota, IndiaLambda Therapeutic Research Ltd.
Sep 13, 2019